Applanation tonometry versus dynamic contour tonometry in eyes treated with latanoprost

Journal of Glaucoma

Volumn 19, Issue 3, 2010, Pages 194-198

  Detorakis, Efstathios T ^a   Arvanitaki, Vasiliki ^a   Pallikaris, Ioannis G ^a   Kymionis, George ^a   Tsilimbaris, Miltiadis K ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Dynamic contour tonometry; Goldmann applanation tonometry; Latanoprost; Rigidity

Indexed keywords

ANTIHYPERTENSIVE AGENT; LATANOPROST; PROSTAGLANDIN F;

AGED; ARTICLE; BIOMETRY; CORNEA; DRUG EFFECT; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; METHODOLOGY; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PATHOLOGY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BIOMETRY; CORNEA; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; TONOMETRY, OCULAR;

EID: 79952051252     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181aae954     Document Type: Article

References (33)

1. Goldmann H. Applanation tonometry. In: Newell FW, ed. Glaucoma Second Conference. New York: J Macy Jr Foundation; 1956: 167-220.
2. Friedenwald JS. Tonometer calibration; an attempt to remove discrepancies found in the 1954 calibration scale for Schiotz tonometers. Trans Am Acad Ophthalmol Otolaryngol. 1957;61: 108-222.
3. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh). 1975;53: 34-43.
4. Mark H. Corneal curvature in applanation tonometry. Am J Ophthalmol. 1973;76: 223-224.
5. Francis BA, Hsieh A, Lai MY, et al; Los Angeles Latino Eye Study Group. Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry. Ophthalmology. 2007;114: 20-26.
6. Mark H, Robbins KP, Mark TL. Axial length in applanation tonometry. J Cataract Refract Surg. 2002;28: 504-506.
7. Pakravan M, Parsa A, Sanagou M, et al. Central corneal thickness and correlation to optic disc size: a potential link for susceptibility to glaucoma. Br J Ophthalmol. 2007;91: 26-28.
8. Kaufmann C, Bachmann LM, Thiel MA. Comparison of dynamic contour tonometry with Goldmann applanation tonometry. Invest Ophthalmol Vis Sci. 2004;45: 3118-3121.
9. Milla E, Duch S, Buchacra O, et al. Poor agreement between Goldmann and Pascal tonometry in eyes with extreme pachymetry. Eye. 2009;23: 536-542.
10. Lim KS, Nau CB, O’Byrne MM, et al. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology. 2008;115: 790-795.
11. Husain S, Yates PW, Crosson CE. Latanoprost-induced changes in rat intraocular pressure: direct or indirect? J Ocul Pharmacol Ther. 2008;24: 367-372.
12. Weinreb RN. Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc. 2001;99: 319-343.
13. Kim JW, Lindsey JD, Wang N, et al. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci. 2001;42: 1514-1521.
14. Sen E, Nalcacioglu P, Yazici A, et al. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness. J Glaucoma. 2008;17: 398-402.
15. Arcieri ES, Pierre Filho PT, Wakamatsu TH, et al. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension. Eye. 2008;22: 179-183.
16. Punjabi OS, Kniestedt C, Stamper RL, et al. Dynamic contour tonometry: principle and use. Clin Experiment Ophthalmol. 2006;34837-34840. Review.
17. Ozbek Z, Cohen EJ, Hammersmith KM, et al. Dynamic contour tonometry: a new way to assess intraocular pressure in ectatic corneas. Cornea. 2006;25: 890-894.
18. Drance SM. The coefficient of scleral rigidity in normal and glaucomatous eyes. Arch Ophthalmol. 1960;63: 668-674.
19. Agrawal KK, Sharma DP, Bhargava G, et al. Scleral rigidity in glaucoma, before and during topical antiglaucoma drug therapy. Indian J Ophthalmol. 1991;39: 85-86.
20. Ebneter A, Wagels B, Zinkernagel MS. Non-invasive biometric assessment of ocular rigidity in glaucoma patients and controls. Eye. 2009;23: 606-611.
21. Kotecha A, White ET, Shewry JM, et al. The relative effects of corneal thickness and age on Goldmann applanation tonometry and dynamic contour tonometry. Br J Ophthalmol. 2005;89: 1572-1575.
22. Lass JH, Eriksson GL, Osterling L, et al; Latanoprost Corneal Effects Study Group. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: a double-masked, randomized, one-year study. Ophthalmology. 2001;108: 264-271.
23. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and metaanalysis approach. Surv Ophthalmol. 2000;44: 367-408.
24. Brandt JD, Beiser JA, Kass MA, et al. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108: 1779-1788.
25. Pepose JS, Feigenbaum SK, Qazi MA, et al. Changes in corneal biomechanics and intraocular pressure following LASIK using static, dynamic, and noncontact tonometry. Am J Ophthalmol. 2007;143: 39-47.
26. Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis. J Cataract Refract Surg. 2005;31: 146-155.
27. Stjernschantz JW, Albert DM, Hu DN, et al. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol. 2002;47(suppl 1): S162-S175.
28. Oh DJ, Martin JL, Williams AJ, et al. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Invest Ophthalmol Vis Sci. 2006;47: 953-963.
29. Marchini G, Ghilotti G, Bonadimani M, et al. Effects of 0.005% latanoprost on ocular anterior structures and ciliary body thickness. J Glaucoma. 2003;12: 295-300.
30. Marques Pereira ML, Katz LJ. Choroidal detachment after the use of topical latanoprost. Am J Ophthalmol. 2001;132: 928-929.
31. Lefrançois A. Pression intraoculaire angle irido-cornéeen, corps ciliaire. In: Mondon H, Metge P, eds. La Myopie Forte. Paris: Masson; 1994: 104-112.
32. Harasymowycz PJ, Papamatheakis DG, Ennis M, et al; Travoprost Central Corneal Thickness Study Group. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea. 2007;26: 34-41.
33. Pallikaris IG, Kymionis GD, Ginis HS, et al. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci. 2005;46: 409-414.